Peer-reviewedCC BYBiomedicines
Normal-Tissue Absence, Rather Than Cross-Patient Prevalence, Limits a Fixed Splice-Junction Panel in Hepatocellular Carcinoma: From a Pre-Specified In Silico Screen to a Genome-Wide Analysis
Related
- Preoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma
- Precision surgical oncology for hepatocellular carcinoma
- Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design
- Tonsillar metastasis from hepatocellular carcinoma: a case report and literature review
- The Rationale for Tissue Biopsy in the Era of Precision Hepatocellular Carcinoma Management
BibTeX
@article{anon2026normaltissue,
title = {{Normal-Tissue Absence, Rather Than Cross-Patient Prevalence, Limits a Fixed Splice-Junction Panel in Hepatocellular Carcinoma: From a Pre-Specified In Silico Screen to a Genome-Wide Analysis}},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702348},
note = {CC BY},
}
RIS
TY - JOUR
TI - Normal-Tissue Absence, Rather Than Cross-Patient Prevalence, Limits a Fixed Splice-Junction Panel in Hepatocellular Carcinoma: From a Pre-Specified In Silico Screen to a Genome-Wide Analysis
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13702348
SN - 2227-9059
ER -